NCT05209035View on ClinicalTrials.gov

Evaluation of Trazodone in OSA-MCI

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

May 10, 2022

Primary Completion Date

May 30, 2025

Study Completion Date

December 31, 2025

Conditions

Mild Cognitive ImpairmentObstructive Sleep Apnea

Interventions

DRUG

Trazodone

Trazodone 50mg daily

OTHER

Placebo

Starch 50mg

Trial Locations (1)

Unknown

The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors

collaborator

Hong Kong University of Science and Technology

OTHER

lead

Chinese University of Hong Kong

OTHER